Sweet
Value
Lab
Methodology
Pricing
Halozyme Therapeutics, Inc.
HALO
Healthcare
Biotechnology
NASDAQ
Sign in to watch
$61.63
Market Cap: $7.27B
Valuation
Financials
Forecast
Compare
Historical Price
Solvency
Dividends
Transactions
People
Compare
This section is coming soon.